Doing the right thing
A commitment to corporate citizenship and community service are long standing traditions at Purdue Pharma Canada. As part of our corporate responsibility program, we have three areas of focus:
Sponsorships, donations and grants
Purdue Pharma Canada takes an active role in supporting organizations that try to improve the quality of life where our employees live and work. We provide sponsorships, donations, in-kind service support and grants.
Preventing the diversion and abuse of prescription drugs
The under-treatment of pain and the misuse, abuse and diversion of prescription pain medications are both serious public health problems. Pain affects millions of people each year. Pain medications remain a safe and effective treatment for appropriately selected and monitored patients. Unfortunately, misuse and abuse and diversion of pain medications can lead to tragic consequences, including addiction, overdose and death. Purdue Pharma (Canada) has been committed to providing resources to support the responsible use of prescription opioids for pain. As a pharmaceutical leader in pain medicine, we are acutely aware of the public health risk these powerful medications create, especially when they are diverted, misused and/or abused. That's why we work with health experts and government agencies on efforts to reduce the risk of opioid abuse and misuse without reducing appropriate pain treatment. At Purdue Pharma Canada we support a number of initiatives that address the misuse, abuse and diversion of prescription drugs.
Safe disposal of prescription medicine
Don't throw it out, visit www.healthsteward.ca
Purdue Pharma Canada employees can expect a work environment that focuses on their health and wellness, while providing opportunities to grow, learn, be engaged and fulfilled.
Employees also have the opportunity to give back through volunteer efforts in the community and various fundraising campaigns, such as United Way.
For more information on our Corporate Responsibility initiatives, visit our Archives or contact Corporate Affairs and Communications at 905-420-6400.